Fig. 2
From: Long-term immunological responses to treatment among HIV-2 patients in Côte d’Ivoire
Time to achieving CD4 ≥ 500 cells/μl among patients with baseline CD4 200–500 cells/μl by HIV type
Fig. 2 | BMC Infectious Diseases
From: Long-term immunological responses to treatment among HIV-2 patients in Côte d’Ivoire
Time to achieving CD4 ≥ 500 cells/μl among patients with baseline CD4 200–500 cells/μl by HIV type